INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE
ORDER A TEST Log In Contact Us
Back TO events
August 21 — 23, 2023 WASHINGTON, DC

Booth #216
Conference Session

15th Annual Next Generation Dx Summit

Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the Next Generation Dx Summit and present on how Tempus can support early development through commercial launch.

Schedule a meeting with us
Conference Session
August 21, 2023
live session
Time
11:45am – 12:15pm

Location
Grand Hyatt Washington
1000 H Street, NW Washington, DC 20001
Speaker
Elaine Katrivanos VP, Regulatory Affairs, Tempus

Building a New CDx Ecosystem to Support Early Clinical Development Through Commercial Launch

  • Tempus combines RWD offering with CDx development to optimize biomarker design
  • Support trial enrollment using design controlled IUO tests
  • Improve speed to market using Tempus FDA-approved xT CDx assay
  • Immediate commercial access to 1000s of oncologists in the US and growing internationally

Schedule a meeting with us

We'll be in touch shortly.